Genomic alterations – a Brave New World for cancer treatment?
New meeting on genomics in cancer treatment
The advent of genome sequencing is bringing about a quiet revolution in healthcare. Yet while the thirst for advanced genomic knowledge may seem enticing, doctors know that information without interpretation may not be very useful.
We are pleased to announce a new high-level scientific meeting that explores ways to better use existing research data in order to improve clinical oncologists’ personalised treatment programs for cancer patients.
The 2nd edition of the Molecular Analysis for Personalised therapy meeting (MAP) will be held 23-24 September in London, diving into the most pressing issues in this field.
• What are the actionable genomic alterations in frequent cancers?
• How can we define rules to identify drivers in individuals?
• What are the latest emerging technologies for personalised medicine?
• What can we learn from recent trials?
Medical oncologists, interns, academics, regulators, industry R&D reps and investigators are invited to register for this important gathering to discuss clinical interpretation of molecular tests for metastatic cancers.
A joint initiative of Cancer Research UK, UNICANCER and ESMO, this conference shines a light on the latest medical developments in a constantly evolving field.
JUST ANNOUNCED !
The MAP conference was just granted 12 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME)
Dr Crispin Hiley, The Francis Crick Institute
“The MAP 2015 conference in Paris was a great experience. The science was of very high quality and there was a wide breadth of research presented, by some of the worldâ€™s most excellent scientists, in various cancer types and using different technologies and approaches. One of the best parts of the MAP conference was that there was plenty of opportunity for networking and it was easy to approach the senior PIs and speakers to discuss shared research interests.”
Dr Nicolai Birkbak, The Francis Crick Institute